ES2624853T3 - Composición y procedimiento para antagonistas del receptor del neuropéptido S (NPSR) - Google Patents
Composición y procedimiento para antagonistas del receptor del neuropéptido S (NPSR) Download PDFInfo
- Publication number
- ES2624853T3 ES2624853T3 ES12854821.1T ES12854821T ES2624853T3 ES 2624853 T3 ES2624853 T3 ES 2624853T3 ES 12854821 T ES12854821 T ES 12854821T ES 2624853 T3 ES2624853 T3 ES 2624853T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- nps
- receptor
- neuropeptide
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161568540P | 2011-12-08 | 2011-12-08 | |
| US201161568540P | 2011-12-08 | ||
| PCT/US2012/068257 WO2013086200A1 (en) | 2011-12-08 | 2012-12-06 | Composition and method for neuropeptide s receptor (npsr) antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2624853T3 true ES2624853T3 (es) | 2017-07-17 |
Family
ID=48574884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12854821.1T Active ES2624853T3 (es) | 2011-12-08 | 2012-12-06 | Composición y procedimiento para antagonistas del receptor del neuropéptido S (NPSR) |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9150582B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2788359B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6381445B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012347758B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2858571C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2624853T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013086200A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017246706B2 (en) * | 2016-04-04 | 2020-09-17 | Research Triangle Institute | Neuropeptide s receptor (NPSR) agonists |
| JOP20190060A1 (ar) * | 2016-09-26 | 2019-03-26 | Chugai Pharmaceutical Co Ltd | مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4917489B1 (cg-RX-API-DMAC7.html) * | 1970-01-22 | 1974-05-01 | ||
| EP0140833B1 (de) * | 1983-09-15 | 1988-03-02 | Ciba-Geigy Ag | 5-und 6-Azaphthalide, ihre Isomerengemische, Verfahren zu ihrer Herstellung und ihre Verwendung in druck- und wärmeempfindlichen Aufzeichnungsmaterialien |
| EP0558521A1 (en) * | 1990-11-22 | 1993-09-08 | Janssen Pharmaceutica N.V. | Isonicotinic acid derivatives and related spiro compounds with herbicidal action |
| EP1329508B1 (en) | 2000-10-13 | 2010-09-08 | Takeda Pharmaceutical Company Limited | Novel g protein-coupled receptor protein and dna thereof |
| US6642255B2 (en) * | 2001-01-11 | 2003-11-04 | Bristol-Myers Squibb Pharma Company | 1,2,-Disubstituted cyclic inhibitors of matrix metalloproteases and TNF-alpha |
| US9012407B2 (en) * | 2004-04-23 | 2015-04-21 | The Regents Of The University Of California | Therapies which act on neuropeptide S receptors |
| EP2365748A4 (en) * | 2008-11-13 | 2012-05-02 | Merck Sharp & Dohme | IMIDAZOISOINDOL neuropeptide S RECEPTOR ANTAGONISTS |
| EP2365749A4 (en) * | 2008-11-13 | 2012-05-30 | Merck Sharp & Dohme | Quinolone NEURO PEPTIDE-S-Receptor Antagonists |
-
2012
- 2012-12-06 EP EP12854821.1A patent/EP2788359B1/en active Active
- 2012-12-06 ES ES12854821.1T patent/ES2624853T3/es active Active
- 2012-12-06 JP JP2014546080A patent/JP6381445B2/ja active Active
- 2012-12-06 WO PCT/US2012/068257 patent/WO2013086200A1/en not_active Ceased
- 2012-12-06 US US14/363,079 patent/US9150582B2/en active Active
- 2012-12-06 CA CA2858571A patent/CA2858571C/en active Active
- 2012-12-06 AU AU2012347758A patent/AU2012347758B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2788359A4 (en) | 2015-06-10 |
| CA2858571C (en) | 2021-03-16 |
| AU2012347758A1 (en) | 2014-06-05 |
| US9150582B2 (en) | 2015-10-06 |
| AU2012347758B2 (en) | 2017-01-19 |
| JP2015500293A (ja) | 2015-01-05 |
| CA2858571A1 (en) | 2013-06-13 |
| WO2013086200A1 (en) | 2013-06-13 |
| EP2788359A1 (en) | 2014-10-15 |
| US20150057268A1 (en) | 2015-02-26 |
| EP2788359B1 (en) | 2017-03-01 |
| JP6381445B2 (ja) | 2018-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7675766B2 (ja) | 中枢神経系疾患の処置のための活性医薬化合物の使用 | |
| ES3028377T3 (en) | Fused gamma-carbolines for acute treatment of anxiety or depression | |
| ES2926533T3 (es) | Antagonistas del receptor opioideo kappa y productos y métodos relacionados con los mismos | |
| ES2915266T3 (es) | Derivados de N-[2-(1-bencilpiperidin-4-il)etil]-4-(pirazin-2-il)-piperazin-1-carboxamida y compuestos relacionados como antagonistas del receptor muscarínico 4 (M4) para el tratamiento de enfermedades neurológicas | |
| TWI374141B (en) | Spiro-oxindole compounds and their uses as therapeutic agents | |
| ES2444418T3 (es) | Derivados de tetrahidroquinolina para el tratamiento de trastornos por estrés postraumático | |
| ES2911707T3 (es) | Derivados de heterociclilo opcionalmente condensados de pirimidina útiles para el tratamiento de enfermedades inflamatorias, metabólicas, oncológicas y atoinmunitarias | |
| ES2974248T3 (es) | Compuesto de pirimidin-piperazina sustituido y uso del mismo | |
| ES2787599T3 (es) | Inhibidores de leucemia inv(16) | |
| ES2926918T3 (es) | Tratamiento de síntomas cognitivos y del estado de ánimo en trastornos neurodegenerativos y neuropsiquiátricos con agonistas del receptor de GABAA que contienen alfa5 | |
| BR112016026205B1 (pt) | Moduladores de entrançamento de gene smn2, seu uso e seu processo de preparação, e composições farmacêuticas | |
| TW200808812A (en) | Imidazo compounds | |
| ES2871673T3 (es) | Activador de los canales KCNQ2-5 | |
| JP2008535916A (ja) | スピロ複素環化合物および治療剤としてのその使用 | |
| Thomas et al. | Identification of N-[(5-{[(4-methylphenyl) sulfonyl] amino}-3-(trifluoroacetyl)-1H-indol-1-yl) acetyl]-l-leucine (NTRC-824), a neurotensin-like nonpeptide compound selective for the neurotensin receptor type 2 | |
| JP2008536942A (ja) | 2−ピロリドン誘導体および炎症状態および疼痛の治療のためのその使用 | |
| ES2793929T3 (es) | Antagonistas de V1a para tratar trastornos del sueño por desplazamiento de fase | |
| EA017437B1 (ru) | 3-замещённое-[1,2,3]-бензотриазиноновое соединение для увеличения глутаматергических синаптических ответов | |
| ES2806981T3 (es) | Derivados de benzotiazol | |
| RU98112237A (ru) | Новые производные индол-2,3-дион-3-оксима | |
| ES2632932T3 (es) | Derivados 6-amido de 4,5a-epoximorfinanos para el tratamiento del dolor | |
| US8722896B2 (en) | Prokineticin receptor antagonists and uses thereof | |
| CA3033534A1 (en) | Method for treating pruritus and/or itch | |
| ES2605466T3 (es) | Compuesto de benzacepina | |
| ES2307025T3 (es) | Combinacion de opioides y un derivado de la piperazina para el tratamiento del dolor. |